Nurix Therapeutics Inc
NRIX
$12.73+0.29 (+2.33%)
Jul 6, 2025, 4:00 PM
Financials
| 52Week High | 29.56 | 52Week Low | 8.18 |
| Beta | 2.11 | Current Ratio Annual | 6.46 |
| Current Ratio Quarterly | 6.26 | Market Cap | 970.48M |
| Net Profit Margin TTM | -369.40 | Operating Margin TTM | -408.87 |
| Price To Book | 2.02 | Price To Free Cash Flow TTM | 40.26 |
| Price To Sales TTM | 17.20 | Quick Ratio Annual | 6.36 |
| Quick Ratio Quarterly | 6.11 | Return On Assets TTM | -36.10 |
| Return On Equity TTM | -47.49 | Return On Investment TTM | -47.49 |
| Revenue Growth3Y | 22.40 | Revenue Growth5Y | 11.88 |
| Revenue Growth Quarterly Yoy | 11.26 | Revenue Growth TTMYoy | -30.26 |
| Revenue Per Share TTM | 0.68 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 171 | 27 | 30 | 64 | 51 | 25 | 84.66M | $935.48M |
| Jun 30, 2025 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $0 |
| Change | 171(100%) | 27(100%) | 30(100%) | 64(100%) | 51(100%) | 25(100%) | 84.66M(100%) | $935.48M(100%) |